Home Wanbang Pharmaceutical and Bailing Pharmaceutical Sign Entrusted R&D Cooperation Agreement for First-in-Class Antidepressant BL2601

Wanbang Pharmaceutical and Bailing Pharmaceutical Sign Entrusted R&D Cooperation Agreement for First-in-Class Antidepressant BL2601

May 20, 2026 22:11 CST Updated May 21, 15:11
Wanbang Pharmaceutical Technology

Pharmaceutical CRO Service Provider